Key Stats for Lumentum Stock
- Current Price: $779.89
- Target Price (Mid): ~$3,100
- Street Target: ~$1,105
- Potential Total Return: ~297%
- Annualized IRR: ~35% / year
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Lumentum Holdings (LITE) jumped on August 4 after Reuters reported that the FCC is drafting a rule to ban U.S. imports of new-model Chinese optical transceivers, the components that move data through fiber inside AI data centers, on national-security grounds. Shares rose roughly 7% intraday on the report, with Coherent up about 11% and Applied Optoelectronics up about 18%, as investors priced in what a supply shift toward Western vendors could mean. If the rule is finalized, American cloud operators would need new suppliers, and Lumentum and Coherent are the two Western names with competitive technology.
The gap between a report and a signed policy is the whole risk here. This is a draft rule that officials could modify or shelve, and Lumentum is a secondary beneficiary, not the target of the action. It is also capacity-constrained, so even a finalized ban would not convert to revenue overnight. That context matters because the August 3 close of $779.89 already sat about 28% below the 52-week high of $1,085.68, and the peak-to-trough drawdown reached 42.80% on 7/29/26. The AI-optics trade keeps repricing in both directions almost weekly.
Why a Chinese Import Ban Points Toward Lumentum, and Where It Stops
The proposed rule targets Zhongji Innolight, which holds roughly a 27% share of the global data-center transceiver market according to Counterpoint Research. Washington’s concern is that Chinese-controlled hardware inside U.S. AI clusters could enable data theft or service disruption. Removing new Chinese models would push cloud operators like Amazon Web Services toward alternatives, and Lumentum and Coherent sit at the front of that short list.
The earnings call maps this exact fault line. At the Mizuho Technology Conference on June 9, CEO Michael Hurlston said the products Lumentum ships to Chinese hyperscalers total nothing essentially: “the sum total of products that we ship to hyperscalers is zero, to Chinese hyperscalers.” Meanwhile, he noted, “there’s a lot of sourcing of Chinese components that are going into U.S. hyperscalers.” That asymmetry is what the draft rule attacks. Lumentum has been shut out of China while Chinese parts flowed into the U.S., and a ban would begin to tilt that balance back.
The limit is capacity. The Foundation for American Innovation notes that Lumentum and Coherent, while they sell competitive technology, lack the scale to replace Chinese vendors outright. Hurlston said the same at Mizuho, describing the company as undershipping EML demand by more than 30% before any policy shift. A rule that redirects demand toward a supplier already rationing output does not create instant revenue. It lengthens the backlog.
See historical and forward estimates for Lumentum stock (It’s free!) >>>
The Business Underneath the Policy Trade
Strip out the regulatory noise, and the fundamentals are strong on their own. In fiscal Q3 2026, reported May 5, Lumentum posted record revenue of $808.4 million, up 90% year over year, and cleared consensus on adjusted EPS with $2.37 against a $2.27 estimate. Gross margin sits at 40.8% on a trailing basis, and TIKR estimates point toward the high 40s as higher-margin component volume scales. Hurlston told the Mizuho audience the company is “poised to go over $1 billion this quarter,” which would roughly double its highest revenue quarter on record of about $500 million. NVIDIA’s $2 billion investment locked in a slice of laser capacity plus multiyear purchase commitments
That bull case does not need a ban to work. What it cannot fix is valuation. Lumentum trades at around 49 times NTM earnings and about 29 times NTM EV/EBITDA per TIKR. That sits above Cisco at roughly 25 times forward earnings and near Arista at around 49 times, but Lumentum is growing far faster than either, with a forward two-year revenue CAGR TIKR pegs near 85%. The premium is defensible while growth compounds, which is also why a 42.80% drawdown from the high was possible on 7/29/26 with nothing operational breaking. When the multiple does the work, it does the damage too.
See how Lumentum performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $779.89
- Target Price (Mid): ~$3,100
- Potential Total Return: ~297%
- Annualized IRR: ~35% / year
See analysts’ growth forecasts and price targets for Lumentum stock (It’s free!) >>>
TIKR’s mid-case scenario, realized at 6/30/31, points to a target near $3,100, implying roughly 297% total return and an annualized IRR around 35%. The number is aggressive, and it rests on stated assumptions rather than certainty. Two revenue drivers carry it: the scale-out EML and transceiver business already shipping at volume through the 1.6T transition, and the newer CPO, OCS, and NPO segment, Hurlston says, has barely hit the income statement. The margin driver is mix, as component revenue crowds out lower-margin systems work, lifting net margin toward the mid-30s in the mid case. The primary risk is the reverse: if hyperscaler capex slows or the 1.6T transition stalls, orders fall faster than a supply-constrained business can adjust, and a 49-times multiple compresses hard. The upside is that a finalized ban plus an already-sold-out order book pulls forward years of demand. The downside is that the same policy proves slow, gets shelved, or reroutes demand that Lumentum cannot serve for years.
Conclusion
The cleanest test arrives fast. Lumentum reports fiscal Q4 2026 after the close on August 11, with consensus near $990 million in revenue and adjusted EPS around $2.97. Crossing $1 billion in revenue while holding a non-GAAP operating margin in the mid-30s would confirm the margin expansion is durable at scale, and that would matter far more than a day of policy-driven buying. Fall short on either line, and the premium gives back ground quickly, ban or no ban. Watch the revenue and margin lines together on August 11.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in Lumentum?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Lumentum, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Lumentum alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Analyze Lumentum on TIKR Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
